A Long-Term Extension Study to Evaluate the Safety of Filgotinib in Subjects with Crohn's Disease
Brief description of study
The primary objective of this study is to observe the long-term safety of filgotinib in subjects who have completed or met protocol specified efficacy discontinuation criteria in a prior Gilead-sponsored filgotinib treatment study in CD
Clinical Study Identifier: s18-00100
ClinicalTrials.gov Identifier: NCT02914600
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.
